The new deal was built on the successful launch of Halaven and Fycompa in South Africa.

Eric Perakslis' experience with Takeda will help facilitate a new collaboration between the two companies.

Pace Analytical Services has bought Wolfe Laboratories to strengthen its life sciences contract development offerings.

JSR Life Sciences’ parent company will pay NT$12 billion ($400 million) for Crown Bioscience International, boosting its global footprint and CRO offerings.

Kentucky-based CRO CTI Clinical Trial and Consulting Services acquires Portuguese counterpart Eurotrials.

The product of a merger of Pluriomics and Axiogenesis, iPSC company Ncardia has signed licensing deals with Roche and Evotec.

ERT has snatched up iCardiac Technologies, which pioneered precision QT studies in early-phase clinical research.

X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.